US Edition
News from Cardiovascular News
We’ve assigned a rating of Unknown factuality to Cardiovascular News. You can read more about how we’ve determined Cardiovascular News’s credibility and reliability as a news source here: https://ground.news/rating-system.
Information about Cardiovascular News
Where is Cardiovascular News located?Cardiovascular News's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Cardiovascular News News
Medical · Wayne CountyNew study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus-eluting balloons with bailout stenting only if necessary was noninferior to routine drug-eluting stent (DES) implantation as part of the treatment for de novo coronary artery disease.See the Story
Sirolimus-Eluting Balloon Strategy Matches Drug-Eluting Stents in Large International PCI Trial
78% Center coverage: 18 sources
HealthcareRobert Lookstein The use of mechanical thrombectomy, specifically computer-assisted vacuum thrombectomy (CAVT) using the 16Fr Lightning Flash system (Penumbra), with anticoagulation achieves superior reduction in right heart strain compared to anticoagulation therapy alone in patients with acute intermediate-high-risk pulmonary embolism (PE). This is according to data presented at the 2025 Transcatheter Cardiovascular Therapeutics (TCT) conferen…See the Story
TCT 2025: STORM-PE finds mechanical thrombectomy superior to anticoagulation alone
100% Center coverage: 1 sources
San Francisco, California · San FranciscoRobin Nijveldt New data suggest that interventionalists can safely opt to defer the treatment of non-culprit lesions when addressing ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease. This is the finding at three years of a trial of two revascularisation strategies for STEMI in patients with multivessel disease, in which instantaneous wave-free ratio (iFR)-guided revascularisation was shown not to be supe…See the Story
